Myovant Sciences Ltd. Additional Paid in Capital
Myovant Sciences Ltd. had Additional Paid in Capital of $835.75 million as of 2022-12-31, per its 10-Q filed 2023-01-26.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2023-01-26
- 2022-12-31: Additional Paid in Capital $835.75M.
- 2022-09-30: Additional Paid in Capital $823.02M.
- 2022-06-30: Additional Paid in Capital $807.13M.
- 2022-03-31: Additional Paid in Capital $795.93M.
| Period end | Additional Paid in Capital |
|---|---|
| 2022-12-31 | $835.75M 10-Q · filed 2023-01-26 |
| 2022-09-30 | $823.02M 10-Q · filed 2022-10-26 |
| 2022-06-30 | $807.13M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $795.93M 10-Q · filed 2023-01-26 |
| 2021-12-31 | $777.84M 10-Q · filed 2022-01-26 |
| 2021-09-30 | $763.75M 10-Q · filed 2021-10-26 |
| 2021-06-30 | $725.47M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $709.47M 10-K · filed 2022-05-11 |
| 2020-12-31 | $711.41M 10-Q · filed 2021-02-11 |
| 2020-09-30 | $702.70M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $694.38M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $684.38M 10-K · filed 2021-05-11 |
| 2019-12-31 | $678.03M 10-Q · filed 2020-02-10 |
| 2019-09-30 | $657.78M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $649.81M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $505.85M 10-K · filed 2020-05-18 |
| 2018-12-31 | $473.52M 10-Q · filed 2019-02-07 |
| 2018-09-30 | $430.10M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $350.31M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $266.18M 10-K · filed 2019-05-24 |
| 2017-12-31 | $262.51M 10-Q · filed 2018-02-13 |
| 2017-09-30 | $256.88M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $254.11M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $251.73M 10-K · filed 2018-06-07 |
| 2016-12-31 | $249.49M 10-Q · filed 2017-02-13 |
| 2016-09-30 | $17.41M 10-Q · filed 2016-12-09 |
| 2016-03-31 | $1.43M 10-K · filed 2017-06-14 |